NextGen Healthcare, Inc.
NXGN · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -7.08 | -0.35 | 0.03 | -1.00 |
| FCF Yield | -1.19% | -1.56% | -0.05% | -0.56% |
| EV / EBITDA | 92.88 | 59.49 | -170.91 | 63.52 |
| Quality | ||||
| ROIC | 0.85% | 1.25% | -2.93% | 1.17% |
| Gross Margin | 46.27% | 44.79% | 47.34% | 47.28% |
| Cash Conversion Ratio | -1.86 | -1.32 | -0.30 | 0.28 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.14% | 5.83% | 5.46% | 4.46% |
| Free Cash Flow Growth | -13.35% | -2,618.80% | 91.11% | -124.74% |
| Safety | ||||
| Net Debt / EBITDA | 11.26 | 9.46 | -22.69 | 1.70 |
| Interest Coverage | 2.43 | 3.78 | -5.93 | 4.27 |
| Efficiency | ||||
| Inventory Turnover | 3.44 | 12.98 | 12.94 | 10.78 |
| Cash Conversion Cycle | 76.87 | 50.73 | 42.87 | 39.59 |